What is Global Anti-inflammatory Therapy Market?
The Global Anti-inflammatory Therapy Market is a vast and dynamic sector that encompasses a wide range of treatments aimed at reducing inflammation in the body. This market includes various types of therapies such as corticosteroids, anti-inflammatory biologics, non-steroidal anti-inflammatory drugs, and others. These therapies are used to treat a variety of conditions, including respiratory diseases, arthritis, gastroenterology issues, dermatology conditions, and more. The market is driven by the increasing prevalence of these conditions worldwide, as well as the ongoing development of new and more effective anti-inflammatory therapies.
Corticosteroids, Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs, Others in the Global Anti-inflammatory Therapy Market:
Corticosteroids are a type of anti-inflammatory medication that is commonly used to treat conditions such as asthma, arthritis, and certain skin conditions. They work by reducing inflammation and suppressing the immune system. Anti-inflammatory biologics, on the other hand, are a newer class of drugs that are used to treat conditions such as rheumatoid arthritis and psoriasis. They work by targeting specific parts of the immune system to reduce inflammation. Non-steroidal anti-inflammatory drugs (NSAIDs) are a broad class of drugs that include common over-the-counter medications like ibuprofen and aspirin. They work by reducing the production of substances in the body that cause inflammation. Other types of anti-inflammatory therapies include natural remedies, such as certain herbs and dietary supplements, as well as physical therapies like massage and acupuncture.
Respiratory Diseases, Arthritis, Gastroenterology, Dermatology, Others in the Global Anti-inflammatory Therapy Market:
The use of anti-inflammatory therapies is widespread across a variety of medical fields. In respiratory diseases, for example, corticosteroids are often used to reduce inflammation in the airways, making it easier for patients to breathe. In the field of arthritis, both corticosteroids and anti-inflammatory biologics are commonly used to reduce joint inflammation and relieve pain. In gastroenterology, NSAIDs are often used to treat conditions like inflammatory bowel disease, while in dermatology, a variety of anti-inflammatory therapies are used to treat conditions like psoriasis and eczema. Other areas where these therapies are used include ophthalmology, where they are used to treat conditions like uveitis, and neurology, where they are used to treat conditions like multiple sclerosis.
Global Anti-inflammatory Therapy Market Outlook:
The global Anti-inflammatory Therapy market has shown significant growth in recent years. In 2022, the market was valued at US$ 118290 million and is projected to reach US$ 168750 million by 2029. This represents a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2023-2029. The market is dominated by several key players, with AbbVie holding the largest market share of 21.59% in 2019. Other significant players in the market include Johnson & Johnson, Amgen Inc, and AstraZeneca PLC, which accounted for 14.20%, 5.43%, and 5.32% of the market share respectively in 2019. These figures highlight the competitive nature of the market and the significant role these companies play in the development and distribution of anti-inflammatory therapies.
| Report Metric | Details |
| Report Name | Anti-inflammatory Therapy Market |
| Accounted market size in 2023 | US$ 118290 million |
| Forecasted market size in 2029 | US$ 168750 million |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
